Drug Profile
Research programme: HIV vaccines - Immunotech Laboratories
Alternative Names: Immune therapeutic vaccine-2; Immune therapeutic vaccine-3; Immune therapeutic vaccine-4; Inactivated pepsin fraction HIV vaccine - Immunotech Laboratories; IPF-ITV; IPF-ITV-2; IPF-ITV-3; Irreversible pepsin fraction HIV vaccine - Immunotech Laboratories; ITV-2; ITV-3; ITV-4Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Immunotech Laboratories
- Class AIDS vaccines; Peptide vaccines
- Mechanism of Action HIV envelope protein gp120 inhibitors; HIV envelope protein gp41 inhibitors; HIV fusion inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(In children) in USA (Parenteral)
- 26 Apr 2013 Immunotech files an IND application with the FDA in US for HIV infection